From the Journals

Hormonal IUDs have higher expulsion rates immediately postpartum


 

FROM THE AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Hormonal intrauterine devices inserted immediately postpartum had a nearly six times greater likelihood of expulsion compared with copper IUDs, but most women who requested any type of long-acting reversible contraception (LARC) postpartum were still using it half a year later, a recent study found.

An IUD flocu/ThinkStock
The researchers followed 350 patients for 6 months after they requested a postpartum insertion of an IUD between October 2013 and February 2016. Of the 325 women who received the LARC device they requested before discharge, 27% received a copper IUD, 38% received a levonorgestrel IUD, and 35% received an implant. The other 25 women did not get their requested device before discharge (Am J Obstet Gynecol. 2017 Mar 23. doi: 10.1016/j.ajog.2017.03.015).

Ninety percent of the patients were Hispanic, 87% had prior children, and 87% had an income below $24,000. Most (77%) had a vaginal delivery. Those who requested the copper IUD tended to be older and have more children compared with those who asked for the hormonal IUD or implant.

Among the 289 patients who completed the 6 months of follow-up, 17% of those with a hormonal IUD had an expulsion, compared with 4% of women with copper IUDs. That translated to a 5.8 times greater risk of expulsion for hormonal IUDs than for copper ones after the researchers accounted for age, mode of delivery, parity, and any breastfeeding. Expulsion rates were statistically similar between those who had vaginal deliveries and those who had cesarean deliveries.

Just 8% of the women requested removal of their device during the 6 months of follow-up. Most (67%) of the 21 women who had expulsions asked for a replacement. Cost of the device delayed or prevented replacement in some cases. Over the next 2 years, 6 of the 11 women who did not get replacement devices became pregnant.

Meanwhile, 81% of women with a hormonal IUD (88% including replacements), 83% with a copper IUD (86% including replacements), and 90% with an implant were still using that device 6 months later. A quarter of the women who completed the study follow-up reported that they did not return to their providers for their postpartum exams.

“For patients at high risk of rapid repeat pregnancy or who may not return for a postpartum visit, the benefit of placement of a highly effective method of contraception in the hospital prior to discharge may outweigh the increased risk of expulsion,” the researchers wrote. “In some states, by 8 weeks, public insurance coverage may expire and women face much more challenging obstacles to affordable, highly effective birth control options.”

The University of Utah and the Eunice Kennedy Shriver National Institute of Child Health and Human Development funded the research. The University of Utah receives research funding from LARC manufacturers and one of the coauthors reported financial relationships with LARC manufacturers.

Recommended Reading

Sterilization rates decline for women despite coverage
MDedge Family Medicine
Injectable male contraceptive on par with other reversible options
MDedge Family Medicine
FDA finalizes boxed warning for Essure
MDedge Family Medicine
Immediate postpartum LARC requires cross-disciplinary cooperation in the hospital
MDedge Family Medicine
VIDEO: Patient survey data yield useful information on acne and different contraceptives
MDedge Family Medicine
Quality group endorses new contraception measures
MDedge Family Medicine
High continuation rates for IUDs, implants at 2 years
MDedge Family Medicine
Oral contraceptive use confers long-term cancer protection
MDedge Family Medicine
Judge blocks Texas attempt to defund Planned Parenthood
MDedge Family Medicine
Increased IUD use suggests ‘Trump effect’
MDedge Family Medicine